> **来源：[研报客](https://pc.yanbaoke.cn)** ```markdown ### 🦷 Healthcare Services PE Trends & Investment Strategies (Q1 2023) #### Review of Private Equity Activity - **Deal Volume Decline**: PE investment activity in healthcare services saw a -21.5% YoY decrease in Q1 2023 (200 deals), ending a five-quarter decline while still surpassing pre-2018 averages. - **Leverage & Valuation Adjustments**: With shifting interest rates and reduced bank loans (now ~4-5x vs. 6x), hospitals/residential facilities face capital pressures. Multiples for growth deals lagged 2021 levels, except in mental health. - **Process & Risk Mitigation**: Deal processes are slower and more cautious. Seller earnouts reemerged to bridge valuation gaps, reflecting post-2021 competitiveness. --- #### Shift in Investment Strategies & Target Sectors - **Focus**: Sponsors prioritize cash-pay segments (e.g., medspa, private duty home, dentistry) and durable-growth business lines, especially in workforce-shortage areas. - **Strategies**: Minority equity injects for growth acceleration (e.g., Team Health) and platform buyouts via “wait-and-see” sponsor-to-sponsor deals (United Digestive & Novocardia). Cash-pay services appear resilient amid recession fears. --- #### Regulatory Developments & Financial Implications - **Medicare Advantage (MA)**: RADV rules tighten HCC coding scrutiny, squeezing MA plan margins via increased recoupments; blended risk-adjustment models rollout (33% new methodology) may pressure revenue. - **High-Yield Debt**: Morningstar data shows ~22% of healthcare services bonds are distressed (25% in healthcare overall), signaling capex strains, especially with ongoing wage inflation. --- #### Market Structure & Deal Dynamics - **Market Map**: PE ecosystem concentrated in leadership-focused specialties (cardiology, oncology) and cash-heavy services (skill care, behavioral health). - **Sector-Specific Deal Trends**: - **Generalist Providers**: Primary care and emergency services record steady activity. - **Multispecialty**: High-volume specialties like cardiology (up 5% YoY) lead deal activity, though valuations remain premium (~$200M-+$1B). - **Mental Health**: Services platform scarcity pushes valuations upward, despite inflation/multiples pressure. --- #### Reverse Mergers & Exit Outlook - **Recent Acquisitions**: Heart and Vascular Partners acquired United Cardiology Partners; TPG-backed OneOncology sale to AmerisourceBergen signals larger deals possible via consolidation. - **Exit Drivers**: Shrinking buyout opportunities and growing financial pressures delayed exits. Single-digit multiples recorded in distressed assets (e.g., ProMedica’s assets) weighed heavily on IRR targets. --- #### Investment Takeaways - **Valuation Realignment**: Across services, PE-backed deals reflect a new normal—lower multiples, higher scrutiny on margins, and earlier work on VBC platforms. - **Geographical & Sector Neutrality**: Key risks include regulatory shifts (MA recoupments) and workforce trends, but cash-pay services could provide exits if recession hits aggressive growth sectors. ```